GTHP Stock Overview - The Average Joe

Newsletter

Latest Issues Subscribe

Company

About Us Jobs
PNK:GTHP

Loading...

Market cap

$Loading...

Sector

Loading...

Dividend Yield

Loading...

52-week range

Loading... Loading...

Expected earnings date

August 8, 2024

Description

Loading...

Returns 1M 6M 1Y 5Y 10Y
$GTHP N/A N/A N/A N/A N/A
S&P500 N/A N/A N/A N/A N/A
Valuation P/E Ratio (TTM) P/S Ratio (TTM)
Guided Therapeutics, Inc. Loading... Loading...
Sector Name Loading... N/A

Related

NEPHNephros, Inc.6.6%
IGXTIntelGenx Technologies Corp.0.0%
SNWVSANUWAVE Health, Inc.-5.6%
ELTPElite Pharmaceuticals, Inc.-3.4%
SCIESpectraScience, Inc.0.0%

Analyst Ratings

Buy Loading...
Hold Loading...
Sell Loading...

Financial Overview

FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023
Revenue1M1M1M0M0M0M0M0M0M0M
Growth Rate--26.4%-0.2%-59.7%-76.6%-36.8%183.3%-20.6%-84.0%653.8%
EBITDA-9M-6M-3M-3M-1M-1M-1M-2M-3M-3M
EBITDA Margin-1,053.3%-1,027.6%-418.0%-1,184.4%-2,573.7%-2,411.1%-765.7%-2,187.7%-24,961.5%-3,440.8%
Net Income-10M-7M-4M-11M1M-3M-1M-4M-5M-3M
NI Margin-1,200.9%-1,138.9%-656.2%-4,383.6%1,782.5%-9,391.7%-1,308.8%-4,601.2%-38,246.2%-3,560.2%
×

Become a better investor with our free daily newsletters

Join 250,000+ investors discovering new market trends and ideas.